Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-956-0 | CAS number: 67953-76-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 12 2010 to June 28 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint:
- genetic toxicity in vitro, other
- Remarks:
- Bacterial mutagenicity, mammalian mutagenicity and mammalian cytogenicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- See read-across justification in IUCLID Section 13
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Remarks:
- No evidence of cytotoxicity
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Remarks:
- No evidence of cytotoxicity
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Remarks:
- No evidence of cytotoxicity
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Remarks:
- No evidence of cytotoxicity
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 3450 µg/ml (free acid), 24 h exposure
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Sodium Salts of (1-Hydroxyethylidene)bisphosphonic acid (2-3 Na:1)
- EC Number:
- 701-238-4
- Molecular formula:
- HEDP-2Na C2H6Na2O7P2 HEDP-3Na C2H5Na3O7P2
- IUPAC Name:
- Sodium Salts of (1-Hydroxyethylidene)bisphosphonic acid (2-3 Na:1)
- Test material form:
- solid - liquid: aqueous solution
Constituent 1
Method
- Target gene:
- Thymidine Kinase Locus
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RPMI
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Additional strain / cell type characteristics:
- other: Clone 3.7.2C
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/Beta-Naphthoflavone induced Rat liver S9
- Test concentrations with justification for top dose:
- Experiment I, with and without S9 mix: 575, 1150, 2300, 4600, 9200, 18400 µg/ml (equivalent to 556-1784.8 µg/ml active acid);
Experiment II, without S9 mix: 287.5, 575, 1150, 2300, 3450, 4600 µg/ml (equivalent to 27.9-446 µg/ml active acid)
with S9 mix: 656.3, 1312.5, 2625, 5250, 10500, 21000 µg/ml (equivalent to 64-2067 µg/ml active acid).
without S9 mix: 21000 µg/mL (equivalent to 2067 µg/ml active acid).
Following the expression phase of 48 hours, the cultures at the lowest concentrations of 575 µg/ml in experiment I with and without metabolic activation were not continued since a minimum of only four analysable concentrations is required by the guidelines. In experiment II the concentrations at 287.5 µg/mL without metabolic activation and 656.3 µg/mL with metabolic activation were not continued for the same reason. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: deionised water
- Justification for choice of solvent/vehicle: solubility properties
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- deionised water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- deionised water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- ACTIVATION: Phenobarbital/beta-naphthoflavone induced rat liver S9, NADP and glucose-6-phosphate as cofactors, final concentration in medium:5 % (v/v)
METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: none
- Exposure duration: 4 hours with and without metabolic activation in experiment 1, 4 hours and 24 hours without metabolic activation in experiment and 4 hours with metabolic activation in experiment 2
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): 10 to 15 days
SELECTION AGENT (mutation assays): RPMI 1640 medium by addition of 5 µg/ml TFT
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: >1,5 x 10 exp. 6 cells
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
DURATION
- Preincubation period:
- Exposure duration: first experiment: 4 hours treatment with and without metabolic activation; second experiment: 24 hours treatment without metabolic activation, 4 hours treatment with metabolic activation
- Expression time (cells in growth medium): 48 h
- Selection time (if incubation with a selection agent): 10-15 days
SELECTION AGENT (mutation assays): TFT
NUMBER OF REPLICATIONS: duplicate cultures; negative result in first experiment confirmed in second experiment
DETERMINATION OF CYTOTOXICITY
- Method: relative suspension growth
OTHER EXAMINATIONS:
- Other: size distribution of colonies - Evaluation criteria:
- A test item is classified as mutagenic if the induced mutation frequency reproducibly exceeds a threshold of 126 colonies per 10 exp. 6 cells above the corresponding solvent control or negative control, respectively.
A relevant increase of the mutation frequency should be dose-dependent.
A mutagenic response is considered to be reproducible if it occurs in both parallel cultures.
However, in the evaluation of the test results the historical variability of the mutation rates in negative and/or vehicle controls and the mutation rates of all negative and/or vehicle controls of this study are taken into consideration.
Results of test groups are generally rejected if the relative total growth and the cloning efficiency are less than 10 % of the vehicle control unless the exception criteria specified by the IWGT recommendations are fulfilled.
Whenever a test item is considered mutagenic according to the above mentioned criteria, the ratio of small versus large colonies is used to differentiate point mutations from clastogenic effects. If the increase of the mutation frequency is accompanied by a reproducible and dose dependent shift in the ratio of small versus large colonies clastogenic effects are indicated. - Statistics:
- Linear regression analysis (least squares) using SYSTAT 11 (SYSTAT Software, Inc., 501, Canal Boulevard, Suite C, Richmond, CA 94804, USA)
Results and discussion
Test results
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 3450.0 µg/ml (free acid), 24 h exposure
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Not affected
- Effects of osmolality: Not increased
- Evaporation from medium: Not examined
- Water solubility: 12 %
- Precipitation: No precipitation was observed by the unaided eye up to the maximum concentration.
- Other confounding effects: None
RANGE-FINDING/SCREENING STUDIES:
The highest concentration level of a pure substance should be 10 mM (corresponding to 2.28 mg/ml of the active ingredient) unless limited by the toxicity of the test item (reduced cell culture growth and/or cloning efficiency). Thus the maximum concentration in the pre-experiment was 2.28 mg/ml of the active ingredient or 18.4 mg/mL of the test item as supplied based on a purity of 12.4%. Test item concentrations between 143.8 and 18400 µg/ml were used to evaluate toxicity in the presence (4 h treatment) and absence (4 h and 24 h treatment) of metabolic activation.
No relevant toxic effect occurred up to the maximum concentration tested with and without metabolic activation following 4 hours of treatment with and without metabolic activation. After 24 hours treatment strong toxic effects occurred at 4600 µg/mL and above.
COMPARISON WITH HISTORICAL CONTROL DATA: Performed
ADDITIONAL INFORMATION ON CYTOTOXICITY:
No relevant toxic effects indicated by a relative total growth of less than 50 % of survival in both parallel cultures were observed up to the maximum concentration with and without metabolic activation, following 4 hours of treatment. In experiment II following 24 hours treatment without metabolic activation, cytotoxic effects as described above occurred at 3450 and 4600 µg/mL. Based on the steep cytotoxic gradient of the test item the relative total growth (RTG) of both parallel cultures fell short of the lower limit of approximately 10%. However, according to the current IWGT recommendations data at RTG levels between 1 and 10% can be used to support a non mutagenic result provided that the dose spacing was 2.0 or lower and no relevant increase of the mutation frequency is observed at RTG levels below 10%.
Any other information on results incl. tables
Summary Table
conditions | conc. µg/ml (aqueous salt solution | conc. µg/ml (free acid) | S9 mix | relative total growth | mutant colonies/ 106cells | threshold | relative total growth | mutant colonies/ 106cells | threshold |
Experiment I / 4 h treatment | culture I | culture II | |||||||
Solv. control with water | - | 100.0 | 113 | 239 | 100.0 | 95 | 221 | ||
Pos. control with MMS | 19.5 | - | 30.6 | 309 | 239 | 33.0 | 299 | 221 | |
Test item | 575.0 | 72.1 | - | culture was not continued# | culture was not continued# | ||||
Test item | 1150.0 | 144.1 | - | 71.7 | 254 | 239 | 156.4 | 115 | 221 |
Test item | 2300.0 | 288.3 | - | 70.2 | 168 | 239 | 110.0 | 177 | 221 |
Test item | 4600.0 | 576.6 | - | 61.0 | 226 | 239 | 136.8 | 149 | 221 |
Test item | 9200.0 | 1153.2 | - | 86.3 | 165 | 239 | 98.2 | 131 | 221 |
Test item | 18400.0 | 2306.3 | - | 74.3 | 184 | 239 | 85.6 | 170 | 221 |
Experiment I / 4 h treatment | culture I | culture II | |||||||
Solv. control with water | + | 100.0 | 165 | 291 | 100.0 | 139 | 265 | ||
Pos. control with CPA | 3.0 | + | 79.1 | 340 | 291 | 49.5 | 144 | 265 | |
Pos. control with CPA | 4.5 | + | 30.7 | 311 | 291 | 23.4 | 344 | 265 | |
Test item | 575.0 | 72.1 | + | culture was not continued# | culture was not continued# | ||||
Test item | 1150.0 | 144.1 | + | 143.5 | 174 | 291 | 83.9 | 183 | 265 |
Test item | 2300.0 | 288.3 | + | 102.5 | 179 | 291 | 88.1 | 92 | 265 |
Test item | 4600.0 | 576.6 | + | 120.4 | 131 | 291 | 80.7 | 107 | 265 |
Test item | 9200.0 | 1153.2 | + | 91.5 | 129 | 291 | 83.7 | 162 | 265 |
Test item | 18400.0 | 2306.3 | + | 76.7 | 149 | 291 | 61.7 | 128 | 265 |
Experiment II / 24 h treatment | culture I | culture II | |||||||
Solv. control with water | - | 100.0 | 189 | 315 | 100.0 | 124 | 250 | ||
Pos. control with MMS | 13.0 | - | 17.9 | 630 | 315 | 12.4 | 489 | 250 | |
Test item | 287.5 | 36.0 | - | culture was not continued# | culture was not continued# | ||||
Test item | 575.0 | 72.1 | - | 60.7 | 178 | 315 | 86.8 | 165 | 250 |
Test item | 1150.0 | 144.1 | - | 66.5 | 149 | 315 | 94.9 | 170 | 250 |
Test item | 2300.0 | 288.3 | - | 70.8 | 144 | 315 | 82.9 | 155 | 250 |
Test item | 432.4 | - | 37.0 | 134 | 315 | 32.1 | 119 | 250 | |
Test item | 4600.0 | 576.6 | - | 5.6 | 102 | 315 | 2.8 | 211 | 250 |
Experiment II / 4 h treatment | culture I | culture II | |||||||
Solv. control with water | + | 100.0 | 173 | 299 | 100.0 | 141 | 267 | ||
Pos. control with CPA | 3.0 | + | 45.7 | 332 | 299 | 35.8 | 497 | 267 | |
Pos. control with CPA | 4.5 | + | 51.7 | 357 | 299 | 50.1 | 427 | 267 | |
Test item | 656.3 | 82.3 | + | culture was not continued# | culture was not continued# | ||||
Test item | 1312.5 | 164.5 | + | 91.4 | 178 | 299 | 98.8 | 154 | 267 |
Test item | 2625.0 | 329.0 | + | 82.9 | 194 | 299 | 74.4 | 163 | 267 |
Test item | 5250.0 | 658.1 | + | 89.4 | 191 | 299 | 73.1 | 178 | 267 |
Test item | 10500.0 | 1316.1 | + | 93.9 | 169 | 299 | 79.0 | 183 | 267 |
Test item | 21000.0 | 2632.0 | + | 96.3 | 183 | 299 | 71.9 | 204 | 267 |
Experiment II / 4 h treatment | culture I | culture II | |||||||
Solv. control with water | - | 100.0 | 159 | 285 | 100.0 | 169 | 295 | ||
Pos. control with MMS | 19.5 | - | 16.1 | 601 | 285 | 17.8 | 639 | 295 | |
Test item | 21000.0 | 2632.0 | - | 74.0 | 203 | 285 | 51.6 | 298 | 295 |
threshold = number of mutant colonies per 106cells of each solvent control plus 126
# culture was not continued since a minimum of four concentrations is required by the guidelines
Applicant's summary and conclusion
- Conclusions:
- In a mammalian cell mutagenicity assay (reliability score 1), conducted according to OECD Test Guideline 476 and in compliance with GLP, HEDP (2-3Na) (neutral pH) was assessed for its induction of mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the presence and absence of metabolic activation. No reproducible, dose-dependent increase in the number of mutations was observed in either the initial or repeat experiment. It is concluded that the test substance is negative for mutagenicity to mammalian cells under the conditions of the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.